HSPA5 and bladder transitional cell carcinoma: Besides, high-expressed HSPA5 largely downregulated the overall survival of 7 types of cancer patients, such as adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), head and neck squamous cell carcinoma (HNSC), kidney renal papillary cell carcinoma (KIRP), GBM, liver hepatocellular carcinoma (LIHC), and uveal melanoma (UVM).